Download Document

NO. THE NAME
TITLE
DEPARTMENT
YEAR NO.S
70-
Nevein farouk
francis
Fludarabine&Cyclophosphamide
Versus COP as first line treatment in
chronic lymphocytic
Leukemia patients
Medical
Oncology
(M.D.)
SUPERVISERS
P.Nasr M. Ali
P.AzzaM.Kamel
P.Thoraya M.
abdel hamid
71-
Inas Mohsen
el-Nady
Protocol Therapy for Newly Diagnosed
All different risk groups
72-
Wael Zekri
Khaled Zekri
Medical
Onc.(Ped.
(M.D.)
Medical
Onc.(Ped.
(M.D.)
73-
Safinaz abdel
habashy
Treatment Plan for newly diagnosed
pediAtric patients with acute lymphoblastic
Leukemia at intermediate or higher risk
Of suspected treatment failure at the NCI
Prognostic significance determination
Medical onc.
pediatric solid tumors
(ped.
(M.D.)
2005
488
P.Moh.Hani H.
P.Azza Kamel
P.ShreifA.E.Naga
p.Mohamed H.H.
p.Azza M.Kamel
p.Manal A. Z.
2002
491
2005
493
P.salah Abdel
hadi
P.Ahmad khalifa
P.Nader Dahaba
2005
498
74-
Hayam fathy abd
el- hay ghazy
Comparative study DHAP verus MINE
chemotherapy treatment relapsed NHL
high grade&correlation mdr- gene
75-
Ahmed Mohamed Treatment newly diagnosed nonkamal
Metastatic osteosarcoma patients NCI
76
Mohamed Elsayed emara
Aphase II studt prolonged ingusion
gemcitabine&cisplatin advanced
bilharzial related bladder ca. correlation
some biological parameters
77
Tarek Mohamed
Ahmed
Intensive conventional chemotherapy
(ACVBP regimen) compared with
CHOP-VP16 for aggressive nonhodgkin’s Iymphoma .
Medical
oncology
(M.B.B.Ch)
Medical
oncology
(M.D. )
Pediatric
oncology.
Medical
oncology
(M.B.B.CH)
Medical onc.
(M.D.)
P.M.Reda Hamza
P.Sameh Sayed
P.Abdel Rahman
zekri
p.W. Yousry G.
p.Sherif A. Naga
P.Iman Sidhom
2006
512
2006
515
p.hussein khaled
p.nayera abdelhmid
p.osman mansour
2006
520
P.Hussein Khaled 2006
P.Zikrw Khaled
P.Fouad Mohamed
529
78
Heba abdelsattar
High dose chemotherapy followed by
allogeneic peripheral blood stem cell
Medical onc.
transplant (PBSCT) using reduced
(M.D.)
intensity conditioning regimens for cases
of high risk non Hodgkin’s lymphoma in
first complete remission.
79
Eman Mohamed
Risk adapted therapy in febrile
neutropenec patients: A prospective
study.
80
Ibrahim abdel
kader S. ahmed
"Impact and management of hepatitis
B&C viral infections on the outcome of
bone marrow transplantation"
Medical onc.
(M.D.)
Medical onc.
(M.D.)
P.ahmed
abdelwarith
P.nadia mokhtar.
P.thoraya abdel
hamid.
P.heba Mohamed
P.nasr Mohamed.
P.hadeer ahamed.
P.alaa el-hadadd
P.manal hamdy
P.hadir A.elmahalawy.
2006
533
2007
537
2007
536
81
82
83
Molecular markers as a prognostic factor
in node negative colorectal cancer
Medical onc.
(M.D.)
p.Mostafa M.el
serafi
p.Nasr M.M.ali
p.Abeer ahmed
bahnasi
Samah Fathy
smeary.
Skeletal changes in pediatric
haematological oncological patients
following stem cell transplantation
p.alaa el hadad
p.mohamed said
abdel kader
p.mohamed amr
Mohamed sami
Ayman A.Resmy
Evaluation of cd38,B-2M and ldh as
prognostic factors in cll patients and
correlate them with clinical stage and
response to chemotherapy.
Salem eid salem
M.
Medical onc.
(M.D.)
Medical onc.
(M.D.)
p.mostafa m. elserafi
p.ibrahim a.
p.amr el-sayd.
2007
541
2007
542
2008
546
Hossam eldein
Ahmed Abdel
Moneim.
Amr allah abd elmoniem
84
Yassmine Fawzy
Heida
Risk-Based Neuroblastoma treatment
plan.
Studying the expression profile of cell
cycle regulatory genes in hepatocellular
carcinoma and chronic active hepatitis
Combined chemotherapy(FEC)with
cox-2 Inhibitor versus chemotherapy
(fec)for treatment of locally advanced
breast cancer
Medical onc.
(M.D.)
Medical onc.
(M.D.)
The role of p53,p63 and p73 gene
alterations in the pathogenesis of
bilharzial bladder cancer patients
receiving neoadjuvant chemotherapy
p.M.reda hamza
p.H.el-zawahry
p.A.A.bahnassy
Medical onc.
(M.D.)
p.A.I. El khodary
p.H.M.Khaled
p.thoraya Abdel
hamid.
Medical onc.
(M.D.)
p.A. abdel-warith
P.Abdel-rahman
zekri
p.M.el-sherbini
85
Safaa M.Aly
ramadan
p.Mohamed Hany
M. Hussein
p.Mustafa Ahmed
Elkabany
p.Eman Ali Attia
2008
549
2007
550
2007
553
2007
554
86
Sahar A.K.haleel
Epidemiologic and clinicopathologic
study of wilna tumor in children and
treatment outcome
Medical onc.
(M.D.)
87
Yasser elsayed ali Septic shock in critically III pediatric
elborai
oncology patients with emphasis on the
role of low dose steroid therapy
Medical onc.
(M.D.)
88
Ehab mosaad
abdel ghany
Comparative study between classic chop
and chop+vp16 in treatment of diffse
large cell NHL
p.Samy elbadaey
p.Alaa m.elhadad
p.Mohamed
A.nouh
p.S.Abdel-hadi
p.S.Akel
p.A.M.Mokhtar
2007
559
2008
560
2008
561
Medical onc.
(M.D.)
p.H.M.Khaled
p.A.Abdel warith
p.Abd-rahman
zekry
Medical onc.
(M.D.)
p.H.M.Kamel
p.Nahla M.
el- 2008
sharkawy
p.M.abdel mooti
89
Mosaad
mahmoud elgammal
The prognostic significance of minimal
residual disease in adult patients with
acute lymphoblastic leukemia
564
90
Essam fikry amin
Aphase III randomized study of
neoadjuvant gemcitabine plus
doxorubicin versus fac regimen for
locally advanced breast cancer patients
Medical onc.
(M.D.)
91
Amira diyaa
darwish
92
Alfred elias
namour
New molecular prognostic markers in
adult acute myeloid leukemia
Clinicopathological study and phase II
clinical trial of epithelial ovarian tumors
Medical onc.
(M.D.)
Dina sameh
shalash
94
2008
568
p.Hossam kamel
p.Osman M.M.
P.Dina A.yassin
2008
569
2008
571
2007
574
Medical onc.
(M.D.)
p.M.El-serafi
p.Nayra anwar
p.A.M.abdelwareth
Medical onc.
(M.D.)
p.farida
H.Gadalah
p.H.shaker
p.Lobna refaat
93
Sensitivity and specificity of multiplex
RT-PCR in comparison to conventional
cytogenetics and fish technique for
detection of prognostically significant
translocations in acute leukemia
p.RababM.Gaafar
p.H.M.elzawahry
p.Hoda Ismail
Tamer M.fouad
The prognostic relevance of telomerase
and Bcl-2 in acute myeloid leukemia
Medical onc.
(M.D.)
p.Nasr el-lahlouby
p.Ibrahim abdel2008
salam
p.Nahed abdelwahab
576
95
Treatment plan for newly diagnosed
Ossama M.Maher pediatric patients with advanced stage
lymphoblastic NHL and T-cell ALL at
the national cancer institute
97
Hatem hamdy
A proposed integrated approach to the
care of terminally Ill pediatric patients at Medical onc.
the NCI-Egypt
(M.D.)
Soluble mesothelin-related protein in
malignant pleural mesothioma:a
clinicopathology correlation
2009
577
p.S.abdel-hadi
p.A.H.Aboulsoud
p.Heba kotb
2009
578
2009
580
Medical onc.
(M.D.)
96
Dina hussein
bassiouni
p.M.Hany Hussin
p.Alaa el-hadad
p.Heba S.Moussa
Medical onc.
(M.D.)
p.Rabab gaafar
p.Ibrahim abdelsalam
p.ola khorshid
98
Hisham M.fahmi
Thiopurine S-methyltransferase(TPMT)
genetic polymorphism and clinical
implications on mercaptopurine therapy
Medical onc.
(M.D.)
99
Serum VEGF and clinicopathological
Maha yahia ismail parameters in non small cell lung cancer
100
Results of stem cell transplantation in
Hossam eldeen A. chronic lymphocytic leukemia in
el-ashtokhy
egyptian patients
Medical onc.
(M.D.)
Medical onc.
(M.D.)
101
Shimaa Lutfy
Abo-ElGouth
Treatent Protocol For Childhood
Myelodysplastic Syndrome Or Juvenile
Myelomonocytic Leukemia
p.Sherif aboul
naga
p.Azza M.kamel
p.Hafez farouk
2009
581
2009
582
p.Nasr M. allahloubi
p.M.abdel-mooti
2009
p.Raafat M. abdelfattah
592
p.Rabab gafafar
p.Osman M.M.
P.Bassma M.elgamal
P.Alaa EL hadad
p.Farida Gadalla
p.Lubna Shalaby
Medical Onc.
(M.D.)
2007
604
Nassaif
102
p.Mohamd Hany
p.Manal Hamdy
Mahmoud
Hammad
Mahmod
103
Medical Onc.
(M.Sc.)
Nesreen Aly
Ahmad
Myocardial Dysfunction After Anthra
Cycline Treatment In Asymptomatic
Pediatric Cancer PATIENTS
Sayed Abd El
Hameed Fadel
Early Detection and Treatment Of Fungal
Infection in High Risk Febril
Medical Onc
Neutropenic Pediatric Patients
(M.D.)
104
105
Histopathologlcal Outcome Of Liver
Disease In Hepatitis
(B)and/or(C)Infected Cancer Survivors
Trends Of Pediatric Oncology at
Riham Abd Elaziz National Cancer Institute
Abd Elghani
(NCI),Cairo,Egybt:Frequencies and
Survival From Jan.2001 toJan
Medical Onc
(M.Sc.)
Medical Onc
(M.D.)
106
Asmaa Mohamed
Role Of Serology In Assisting Diagnosi
of Pneumonia
Medical Onc
2009
608
2009
609
2009
610
2009
611
2009
612
P.Alla Elhaddad
p.Hala Hamza
p.Hany Hussein
p.Iman Sidhom
p.Hadir ElMahal
p.M.Hany Husein
p.Samy Ahmed
p.Inas Elattar
p.Lobna Shalaby
p.Hadir ElMahal
p.Lman M.Zaki
Hamoda
107
Ahmed Ibrahim
Ali Elhemaly
108
Rahm Zaki
Ahmed Mohamed
109
Hanafy Ahmed
Mohamed
(M.Sc.)
Aretrospective Study Of Early Deaths
and Treatment-Related Mortality in
Acute Myeloid Leukemia Patients
Treated at Nathonal Cancer Institute in
tha year 2005,2006
Detection of Topisomerase ll in
Hepatocellular Carcinoma Patient
relevant to Chemotherapy Treatment
Risk Adapted Therapy Of Childhood
Rahabdomyosarcoma and
Undifferentiated Sarcoma
Medical Onc
(M.Sc.)
Medical Onc
(M.D.)
p.Iman Saidhom
p.Hadir El Mahal
p.Yasser El-Nahs
2009
613
2009
616
2009
618
2009
620
P.Haba El-Zawah
p.Magda Morad
p.Ahmed Abd wa
P.SamyEl-Badaw
p.Hany Hussein
p.Alaa EL Hadad
p.Hussein Khaled
p.Nabawy Zakri
Medical Onc
(M.D.)
Impact Of Moleclar Prognostic Factors in
110
advanced bladder cacer patiens raceiving Medical Onc
Rasha M.Mostafa chemotherapy
(M.D.)
P.Osman M.
P.Nelly H.
Haggagar
P.Salem eid
M.M.Elkholy
p.Haba Mo.Elza.
p.Magdy M.Sab.
p.Ola Mo.Reda
111
112
Emad Eldin
Abdalla Shash
113
Ahmed El Saied
EL Bastawisy
114
Mohamed Attia
Hasan Sherisher
115
Outcome of treatment in metastatic
breast cancer patients at NCI,2years
series
Prognostic And Predictive Markers For
Hepatocellular Caricinoma
Medical Onc
(M.D.)
Medical
Oncology
(M.Sc.)
Outcome Of Neoadjuvant Chemotherapy
In Lnfammatory Breast Cancer
Medical
Oncology
(M.D.)
The Prognostic Significance Of
Methylated p15 and p73 Genes In Abult
Patints With Acute Lymphoblastic
Leukaemia
Disease Outcome Of Newly Diagnosed
Medical
Oncology
(M.D.)
2010
625
2010
629
p.Zekry Khaled
p.Nayera Hamdy
p.Thorata M.
p.Ghada Ibrahi.
2010
633
p.Sherif Aboulna.
p.Lobna Shalaby
p.Sherine Salem
2010
636
2010
635
P.Rabab Gaafar
p.Saad Said Eisa
p.Gamal Amira
p.Maha Hussein
p. Lobna Shalaby
p. Nelly Hessan
Moatasem M.
Hatem El Ayadi
116
Rania
Mohammed
Bedair
117
Pediatric Acute Myeloid Leukemia
Patients Treated at Children Cancer
Hospital Egypt
Toxicity Profile &Outcome in Patients
With Mature B Cell Lymphoma
Receiving FAB LMB96 Protocol at
National Cancer Institute of Cairo
Treatment plan for for newly diagnosed
pediatric patients with low risk acute
Abeer Hussein M. lymphoblastic leukemia AT NCI
118 Eman Sobhy
Elbanna
Prognostic factors in breast cancer
patients with brain metastasis
119 Ahmed AbdElhamed Elsayed
Anthracycline Based Chemotherapy in
Early Breast Cancer:Correlation With
Receptor Status (Estrogen,progesterone
and human epidermal growth factor-2)
Medical
Oncology
(M.D.)
Medical
Oncology
(M.D.)
Medical
Oncology
(M.D.)
Medical
Oncology
(M.D.)
Medical
Oncology
(M.D.)
p.Hany Abd ElR
P.Azza Kamel
P.Sherif Abou elnaga
P.Emad Ebeid
2010
642
P.Magdy M.S.
P.Ola Khorshid
P.Hanan Ezzat
2010
648
2010
649
2010
651
p.Rabab M. Gaaf
p.Ahmed Abd
Elmabood
p.Amani M.H
p.Magdy M.S.
p.Thoria A. H.
p.Gamal A.M.
p.Heba M.Elzaw.
p.Kyoko
Tsukiyama
120 George Foad
Estafanous
121 Nahla Ahmed
Elgohary M.
Evaluation of different regimens as first
line chemotherapy in metastatic and
recurrent breast cancer
“DHCR24”Relation to Hepatocellular
Carcinoma
122 Emad Saad Abd
El Malek
Management of Wilms Tumors in
pediatric
Medical
Oncology
(M.D.)
Medical
Oncology
(M.D.)
Medical
Oncology
(M.D.)
p.Amin M.A. Abo Gabal
p.Wael Zekri
p.Eman A.Eldebawy
2010
652
p.Iman Sidhom
p.Iman M. Zaki
p. Ahmad M. K.
2010
654
p.Emad Nabil E.
p.Hany Abd Elra.
p.Nahla El
Shsrqawy
2009
655
2009
660
2010
659
123 Omar Shawki
Farid arafah
A Retrospective Study of L-Asparaginase Medical
Induced Thrombosis in Pediatric Acute
Oncology
Lymphoblastic.
(M.D.)
p.Mostafa M. El
Serafy
p.Sameh Sayed
p.Mona Ali Sakr
124 Ahmed Hussein
Al Gammal
Clinical Significance of minimal
Residual Disease in Childhoo Acute
Lymphoblastic Leukemia and its
Relationship to other prognostic Factors
P.Thoraya
M.Abdelhamid
P.Abeer Bahnssy
P.Hanan Ezzat
Medical
Oncology
(M.D.)
125 Shereef Ahmed El Phae II Study of Low dose Fixed Rate
Sammany
Infusion of Gemcitabine With Cisplatatin Medical
and Dexamethazone in Resistant nonOncology
Hodgkin Lymphoma and correlation
(M.D.)
With Mdr and BCL-2 Expression
p.Magdy M. Sa.
p.Ibrahim A.S.
p.Ahmed
Abdelmabood.
126 Asmaa Mahmoud Studying the methylation pattern in cases
M. Elhussainy
of invasive duct carcinoma of the breast Medical
as biomarkers to detect the clinical
Oncology
outcome
(M.D.)
p.Fouad M.A.Ta.
p.Osman M.Man.
p.Nahla E.Sh.
p.Ola M.R.Khor.
127 Sarah Ahmed
Farag
p.Hussein Khaled
p.Nelly Ali Eldin
p.Gamal M.Ab.M
Gasrtrointestinal Tract Cancers in
Egyptian Patients;Comparison between
Elderly and Non-Elderly.
2010
657
2010
667
2010
668
128 Ahmad Abdel
Raheem A.Ab.R.
Low Dose Cytarabine With or Without
Anthracycline in the Induction Treatment
of Elderly Patients With Acute Myeloid
Leukemia.
129 Noha Fouad
M.Rashad
Time Trend Analysis For Colorectal
Cancer in Egypt A Multicenter Study
Abdel-hamid
Mohamed fouad
Medical
oncology(m.sc.)
Medical
Oncology
(M.D.)
2010
671
2010
673
2011
675
P.Heba ElZawahr
P.Ola Khorshid
P.Amani Helal
P.Nasr
M.Allahoubi
P.Fouad M.Abu
Taleb
P.Salem E.Salem
Recent advances in the management of
acute promyelocytic
The Effect of Neoadjuant Therapy on
operable Breast Cancer
670
p.thoria moh.
p.moh. abdelmooti
p.raafat moh.
130
Mohamed Helmy
131 El metenawy
2011
Medical
Oncology
(M.D.)
P.Heba
El.Zawahry
P.M.Abdelmooti
P.Raafat A.
132 Ahmed Barakat
133 Mahmoud ElSawy Mohamed
134 Mona Fawzy
Ramadan
Centreal nervous system metastases in
breast cancer.
Management of fungal infections in
immunocompromised patients.
Medical
Oncology
(M.Sc.)
P.Magdy M.
P.Fouad Moham
P.Thoraya A.H.
P.Abeer A.B.
Medical
Oncology
(M.Sc.)
P.Zekri K.Z.
P.Nadia I.Z.
P.Heba M.R.El.
P.Fouad M.Abu.
Gemcitabine,Dexamethazone,and
Medical
Cicplatine (GDP)As A First Line Salvage Oncology
Treatment of Patients With Refa Ctory or (M.Sc.)
Relapsed Aggressive Nhl.
Assessment of Bisphosphpnates Use as
135 Ola Mohamad El- Adjuvant Therapy in Breast Cancer
Farargy
Medical
Oncology
(M.Sc.)
P.Iman Abd.El.
P.Sonia F.
P.Sahar A. K.
P.Hussein M.
P.Sameh S.
P.Tarek N.
2011
682
2011
685
2011
686
2011
691
136 Diana abd Elaziz
Ehab Osman
Kamel Farag
137 Kamel Ahmed
Seleem
Prognostic Significance of Absolute
Lymphocyte Count in Pediatric Acute
Lymphoblastic Leukemia
Low Dose Prolonged Infusion
Gemcitabine &Cisplatin Versus
Conventional Gemcitabine in Patients
With Advanced Bladder Cancer:Aphase
II Trial
Medical
Oncology
(M D)
p.M.Moh. Saber
P.Moh. Abdelmooti
Medical
Oncology
(M D)
P.Rabab Moh.
Gaafar
P. Fatma Abou
Elkasem
Medical
Oncology
Rashad ahmed
138 mohamed salama
Daoud habib
139 yakoub
2011
693
2011
695
Pronostic factors in multiple myeloma:
National cancer institute experience
P.Dina Nabil
Abbas
P.Sayed Mahmoud
Ahmed
2011
696
Individualization of treatment in nonsmall cell lung cancer
P.Ahmed
Abdelmaboo 2011
P.Salem eid salem
697
Medical
Oncology
(M sc.)
Yasser Mohamed
140 Shafik
Vertebroplasty versus kyphoplasty in
P.Iman sidhom
management of metastatic vertebral bone Medical
P.Heba Moussa
lesions
oncology(M.sc.)
Moh. Saadeldin
141 Rady
Hepaocellualr carcinoma Presenting to
tanta cancer center
Excision repair cross-complementation
group 1(ERCC1) in platinum-based
treatment of non-small cell lung cancer
698
2011
P.Rabab Moh.
Medica
Gaffar
oncology(M.D.) P.Sameh Sayed
Ahmed El hussein Acute Leukemia in children with down
142
syndrome
Mohamed Aly
143 Hussien
2011
Medical
Oncology
(M.SC.)
699
2012
700
P.A. Abdelmabood 2012
P.Hanan Ramadan
P.Mosaad M.
701
Medical
Oncology
144 Dina Al-Saeed M. Treatment outcomes of gastric carcinoma (M.D.)
presenting to tanta cancer center
Amgad
145 A.Shaheen
Hala Aziz
146 Shokralla
Akram Abd El147 aziz Youssef
Wafa Hussein
148 Buhoush
Evaluation of vascular endothelial
growth factor as a prognostic marker in
inoperable hepatocellular carcinoma
Prognostic effect of drug resistance of
glutathione-S-transferase in non small
lung cancer
Palliative care service at the national
cancer institute
Trends in clinical trials to fulfill the
requirements for medical doctorate
degree in medical oncology at the
national cancer institute
Medical
Oncology
(M.D.)
Medical
Oncology
(M.SC.)
Medical
Oncology
(M.SC.)
Medical
Oncology
(M.D.)
P.Heba El zawahry
P.Nadia Zakhary
P.Reda Hassan
2012
704
P.Rabab Gaafar
P.Abeer Bahnassy
P.Amany M. Helal
2012
707
P.A.Abdelmabood
P.Azza Omran
P.Amany HILAL
2012
709
P.A.Zeeneldin
P.Manar M.Moneer 2012
P.Amira Darweesh
710
P.Heba El Zawahry 2012
P.Abdel Hady Aly
P.Amany Helal
711
Marwa Nabil Abd Detection of circulating tumor cells in
149 elhafez Mostfa
peripheral blood as a prognostic marker
in breast cancer
Asmaa M.Ibrahim Transarterial chemoembolisation as
150
method of therapy for advanced
hepatocelluar carcinoma in Egyptian
patients
Haba Fekry Abd
151 El-megeed
Yahia Mahmoud
152 Ismail
Prediction of Response to Tamoxifen by
Cyp2D6 Enzyme Gentype in Metastatic
Breast Cancer
The relevance of Ki67 and p53 to
adjuvant hormonal treatment outcome in
hormone-dependent postmenopausal
breast cancer patients.
Medical
Oncology
(M.SC.)
Medical
Oncology
(M.D)
Medical
Oncology
(M.D)
P.A.Zeeneldin
2012
P.Salem Eid Salem
P.Reda Hasan
P.Nasr M.Aly
P.Samia A.S.
P.Amany M.H.
P.Tarek Ali M.
715
2012
716
P.Heba Elzawahry 2012
P.Nadia Mokhtar
P.Magdy M.Saber
719
2012
720
Moh. Abdelmooti
Medical
p.Raafat moh.
oncology(M.SC) p. Mosaad
mahmoud
Mahmoud moha
Med eldemerdash Recent updares in autologous
153
hematopoietic stem cell transplantation
for management of lymphomas
Dalia hamouda el
154 Sadek el-said
Shereen mostafa
el-shorbagy
155
Medical
oncology(m.d)
p.nasr M. ali
p.Magda mourad
p.fouad moh.
2012
Medical onc.
(m.d)
p.fouad moh.
p.thoraya m. abdel 2012
hamid
p.abeer a. bahnasy
Dose dense choep14 regimen as first line Medical onc.
Treatment of young poor risk dlcl
(m.d)
p.magdy m. saber
p.abeer a. bahnasy 2012
p.moh. abdel
mooti
The correlation between hormne
receptors, HER 2 & Topoisomerase II
&response to neoadjuvant chemotherapy
In locally advaneed breast ca.
723
724
729
Mohamed
156 ghareeb moh.
Evaluation efficacy of treatment
regimens in metastic breast ca. by the
level of circulating tumor cells
Retrospective management of multiple
myeloma
157
Yasser Arafat
hassen
Med.
Onc.(m.sc.)
Medical onc.
(m.d.)
2012
731
2012
733
p.nasr m. ali
p.fouad m. abutaleb
p.alfred elias
namour
p.hussain khaled
p.nadia mokhtar
p.foaad moh.
158
Ahmed
mohammad mohi
Treatment tailored therapy of diffuse
large b-cell non hodgkin's lymphoma
2012
734